Novel Cosmetic Formulation Rapidly Reduces Hair Shedding
September 2024
in “
Journal of the American Academy of Dermatology
”
New to Minoxidil? There is a guide in the encyclopedia. Read the guide →
Studysummary In this prospective, placebo-controlled study, the researchers observed a significant reduction in hair shedding in women after applying the combined topical treatment DA-OTC-002, containing synephrine and TAAR agonists, compared to placebo, showing a 62.5% average reduction with no reported adverse events.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer